Table 4.
Summary estimates of sensitivity and specificity for IgM versus IgG versus IGM or IgG (IgT)
IgM | IgG | IgT | ||
---|---|---|---|---|
Estimate (95 % CI) | Estimate (95 % CI) | Estimate (95 % CI) | ||
Erythema migrans | Sensitivity | 0.426 (0.361 to 0.494) | 0.359 (0.293 to 0.431) | 0.606 (0.503 to 0.700) |
Specifcitiy | 0.953 (0.924 to 0.971) | 0.961 (0.939 to 0.975) | 0.919 (0.885 to 0.944) | |
Neuroborreliosis | Sensitivity | 0.600 (0.526 to 0.669) | 0.589 (0.515 to 0.659) | 0.865 (0.812 to 0.906) |
Specifcitiy | 0.949 (0.924 to 0.966) | 0.956 (0.935 to 0.971) | 0.913 (0.869 to 0.942) | |
Lyme arthritis | Sensitivity | 0.392 (0.279 to 0.517) | 0.941 (0.857 to 0.977) | 0.945 (0.842 to 0.982) |
Specifcitiy | 0.951 (0.881 to 0.980) | 0.969 (0.942 to 0.983) | 0.921 (0.837 to 0.964) | |
Acrodermatitis Chronica Atrophicans | Sensitivity | 0.184 (0.090 to 0.340) | 0.987 (0.821 to 0.999) | 0.978 (0.874 to 0.996) |
Specifcitiy | 0.965 (0.930 to 0.983) | 0.966 (0.952 to 0.976) | 0.932 (0.883 to 0.962) | |
Unspecified Lyme borreliosis* | Sensitivity | 0.596 (0.324 to 0.820) | 0.557 (0.448 to 0.661) | 0.792 (0.960 to 0.867) |
Specifcitiy | 0.911 (0.818 to 0.959) | 0.986 (0.877 to 0.998) | 0.947 (0.725 to 0.992) |
IgT refers to assays measuring IgM and IgG simultaneously. 95 % CI = 95 % confidence interval. *Analyses were not possible for healthy controls; these are the estimates for studies including cross-reacting controls